MyBiome results from years of research on gut microbiota at NOVA Medical School. The company started to be designed in the Health Market Progam from Healthcare City and it was created in June 2019.
The mission of the company is to ensure safe and effective access to the treatment of disorders through fecal microbiota transplantation (FMT) and to develop new forms of application in the human and animal microbiome. MyBiome aims to establish the first production site of microbiome solutions and preparations in Portugal for innovative therapeutics based on FMT.
Organic Unit: NMS|FCM